Day: January 21, 2022

Aaron BarsnessAaron BarsnessSuominen Corporation’s stock exchange release on January 21, 2022 at 2:00 p.m. EET Proposal on the number of the members, on the composition, and on the Chair of the Board of Directors The Nomination Board of Suominen Corporation’s shareholders proposes to the Annual General Meeting that the number of Board members remains unchanged and would be six (6). The Nomination Board proposes to the Annual General Meeting that Andreas Ahlström, Björn Borgman, Jaakko Eskola, Nina Linander and Laura Raitio would be re-elected as members of Suominen Corporation’s Board of Directors. Out of the current Board members, Sari Pajari-Sederholm has informed that she is not available as a candidate for the Board of Directors. In addition, the Nomination Board proposes that Aaron Barsness would be elected...

Administration of one-time hematopoietic stem cell (HSC) gene therapy resulted in sustained, clinically meaningful benefits by preserving cognitive function and motor development in most patients 90% overall survival with up to 7.5 years of follow-up (median 3.2 years) in 29 patients BOSTON and LONDON, Jan. 21, 2022 (GLOBE NEWSWIRE) — Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced the publication in The Lancet of long-term clinical outcomes evaluating the safety and efficacy of Libmeldy® (atidarsagene autotemcel) for the treatment of early-onset metachromatic leukodystrophy (MLD). Libmeldy is the only approved one-time gene therapy intended to correct the underlying cause of MLD for eligible patients in the European Union, UK, Iceland, Liechtenstein and Norway. Also known as OTL-200, it is an...

IvedaIveda Smart UVCMESA, Ariz., Jan. 21, 2022 (GLOBE NEWSWIRE) — Iveda (OTCQB: IVDA), the worldwide provider of IvedaAI™ intelligent video search technology, Sentir® video surveillance products, IvedaPinpoint™ and IvedaHome™ IoT (Internet of Things) platforms with smart devices, today announced the launch of its commercial-grade, AI-driven Ultraviolet Germicidal Irradiation (UVGI) product. This product is the newest addition to Iveda’s smart city portfolio. “With the prevalence of the COVID-19 virus in our lives and its continuous mutation, we may have to assume that it’s not going away,” said David Ly, CEO of Iveda. “Common hygiene, social distancing and masking may not be enough to minimize the spread of the virus. As such, we offer a sensible solution to potentially irradicate all kinds of bacteria and viruses,...

MARYSVILLE, Ohio, Jan. 21, 2022 (GLOBE NEWSWIRE) — The Scotts Miracle-Gro Company (NYSE: SMG) today announced the expiration and results of its previously announced registered exchange offer to exchange any and all of its $400,000,000 aggregate principal amount of 4.375% Senior Notes due 2032, which were issued in a private placement on August 13, 2021 (the “Original Notes”), for an equal principal amount of its 4.375% Senior Notes due 2032, which have been registered under the Securities Act of 1933, as amended (the “Exchange Notes”). The exchange offer expired at 11:59 p.m., New York City time, on January 10, 2022. As of that time, $400,000,000 aggregate principal amount, or 100.0%, of the Original Notes had been validly tendered for exchange and not validly withdrawn. All of the Original Notes validly tendered and not validly...

PHOENIX, Jan. 21, 2022 (GLOBE NEWSWIRE) — Mesa Air Group, Inc. (NASDAQ: MESA) today reported Mesa Airlines’ operating performance for December 2021. Mesa Airlines reported 26,920 block hours in December 2021, a 3.8 percent increase from December 2020. Covid-19 and its impact on employee attendance was a primary factor behind Mesa’s controllable completion factor of 93.05 percent and 97.89 percent for its American and United operations, respectively. Operating statistics for December 2021 and fiscal year 2021 YTD are included in the table below.  Dec-21 Dec-20 % Change YTD FY2022 YTD FY2021 % ChangeBlock Hours            American 10,470   12,400   -15.6 % 33,129   31,368   5.6 %United 16,221   13,316   21.8 % 52,294   37,389   39.9 %DHL 229   217   5.3 % 655   490   33.7 %Total 26,920   25,933   3.8 % 86,079   69,247   24.3 %               Dec-21 Dec-20 %...

NEWARK, N.J., Jan. 21, 2022 (GLOBE NEWSWIRE) — Rafael Holdings, Inc., (NYSE: RFL), a company focused on discovering and developing novel cancer and immune metabolism therapeuties through its Barer Institute and investment in Rafael Pharmaceuticals, Inc. and other early-stage ventures, today announced several changes to its leadership team. William (Bill) Conkling will remain with the Company and assume the responsibilities of Chief Executive Officer from Ameet Mallik as of February 1, 2022. Bill Conkling has over 20 years of experience specializing in the development and commercialization of novel cancer therapeutics and currently serves as Rafael’s Chief Commercial and Business Officer.  Previously, Bill was Vice President Sales, Marketing, Market Access and Commercial Operations at Immunomedics where he built and led the US commercial...

NEW YORK, Jan. 21, 2022 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for over 11,000 U.S. and global securities, today announced Mystic Holdings Inc. (OTCQX: MSTH), a company focused on cannabis cultivation, production and retail, has qualified to trade on the OTCQX® Best Market. Mystic Holdings Inc. upgraded to OTCQX from the Pink® market. Mystic Holdings Inc. begins trading today on OTCQX under the symbol “MSTH.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com. The OTCQX Market provides investors with a premium U.S. public market to research and trade the shares of investor-focused companies. Graduating to the OTCQX Market marks an important milestone for companies, enabling them to demonstrate their qualifications...

COVISHIELD (STI-9167) neutralizing antibody (nAb) was discovered by scientists from the Icahn School of Medicine at Mount Sinai (“Icahn Mount Sinai”) and further optimized and engineered by Sorrento scientists.A preprint manuscript is published online at biorxiv.org: https://biorxiv.org/cgi/content/short/2022.01.19.476998v1 Sorrento has obtained worldwide exclusive license rights from Icahn Mount Sinai as previously announced on March 9, 2021 (https://investors.sorrentotherapeutics.com/news-releases/news-release-details/sorrento-and-mount-sinai-health-system-enter-exclusive-license).Compared to available published literature and head-to-head experiments, STI-9167 nAb is a potentially “Best-in-Class” nAb against the Omicron variant of SARS-CoV-2 and the first reported nAb with high potency against Omicron (+R346K mutation) and has...

MARYSVILLE, Ohio, Jan. 21, 2022 (GLOBE NEWSWIRE) — The Scotts Miracle-Gro Company (NYSE: SMG) today announced that it has extended its registered exchange offer to exchange any and all of its $500,000,000 aggregate principal amount of 4.000% Senior Notes due 2031, which were issued in a private placement on March 17, 2021, for an equal principal amount of its 4.000% Senior Notes due 2031, which have been registered under the Securities Act of 1933, as amended. The exchange offer, which had been scheduled to expire at 11:59 p.m., New York City time, on January 20, 2022, will now expire at 11:59 p.m., New York City time, on January 27, 2022, unless further extended by the Company. All other terms, provisions and conditions of the exchange offer will remain in full force and effect. As of 5:00 p.m., New York City time, on January...